Axon Enterprise, Inc $AXON Stock Position Raised by NFSG Corp

NFSG Corp lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 4,904.6% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 26,224 shares of the biotechnology company’s stock after purchasing an additional 25,700 shares during the period. Axon Enterprise makes up approximately 1.1% of NFSG Corp’s holdings, making the stock its 22nd largest holding. NFSG Corp’s holdings in Axon Enterprise were worth $11,080,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Keating Financial Advisory Services Inc. acquired a new position in Axon Enterprise during the second quarter worth about $31,000. Washington Trust Advisors Inc. raised its holdings in Axon Enterprise by 1,300.0% in the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after acquiring an additional 65 shares during the last quarter. Wealth Enhancement Trust Services Inc. acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $33,000. Delos Wealth Advisors LLC acquired a new stake in Axon Enterprise in the 2nd quarter valued at about $45,000. Finally, Owl Creek Wealth Partners LLC raised its holdings in Axon Enterprise by 84.8% in the 2nd quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 39 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on AXON shares. Barclays raised their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. UBS Group upped their price target on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a report on Thursday, September 17th. Morgan Stanley increased their price target on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, September 2nd. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $718.47.

Insider Activity

In other news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider owned 56,264 shares in the company, valued at $27,032,038.80. This trade represents a 1.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This represents a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 47,397 shares of company stock valued at $26,722,984. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Trading Up 2.1%

Shares of AXON opened at $417.19 on Friday. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $764.02. The firm has a 50-day moving average price of $505.21 and a 200 day moving average price of $475.02. The firm has a market capitalization of $33.89 billion, a P/E ratio of 173.11, a P/E/G ratio of 7.69 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. During the same period last year, the business earned $2.12 earnings per share. Axon Enterprise’s revenue was up 35.3% compared to the same quarter last year. Sell-side analysts forecast that Axon Enterprise, Inc will post 2.12 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.